Insights

Clinical-Stage Oncology Pipeline Oncternal Therapeutics has a diverse pipeline of oncology treatments targeting cancers with critical unmet medical needs. This presents sales opportunities for pharmaceutical partnerships and collaborations to advance novel cancer therapies.

Targeted Therapies Development With a focus on developing therapies that target specific biological pathways involved in cancer progression, Oncternal Therapeutics offers the potential for unique and personalized treatment options. This paves the way for targeted marketing strategies aimed at healthcare providers looking for innovative solutions for their patients.

Tech Stack Utilization Oncternal's utilization of Google Analytics, Amazon Web Services, and other tech tools indicates a commitment to leveraging technology for data-driven decision-making and efficient operations. This technology-focused approach can attract tech-oriented partners seeking to enhance their offerings in the biotech space.

Sustainable Revenue Growth Oncternal's revenue falls within the range of $0 - 10M, illustrating a company with growth potential in the biotechnology sector. This financial health signals an opportunity for sales development representatives to engage with investors interested in supporting emerging biotech companies with promising pipelines.

Strategic Market Positioning Compared to similar companies in the industry, Oncternal Therapeutics' size and revenue place it in a competitive position for expansion. Sales professionals can explore partnership opportunities with Oncternal to tap into its growth trajectory and establish mutually beneficial business relationships.

Oncternal Therapeutics Tech Stack

Oncternal Therapeutics uses 8 technology products and services including Google Analytics, cdnjs, jsDelivr, and more. Explore Oncternal Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • cdnjs
    Content Delivery Network
  • jsDelivr
    Content Delivery Network
  • Akamai
    Content Delivery Network
  • Business Catalyst
    Content Management System
  • Choices
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • ZURB Foundation
    UI Frameworks

Media & News

Oncternal Therapeutics's Email Address Formats

Oncternal Therapeutics uses at least 1 format(s):
Oncternal Therapeutics Email FormatsExamplePercentage
FLast@oncternal.comJDoe@oncternal.com
82%
Last@oncternal.comDoe@oncternal.com
11%
First_Last@oncternal.comJohn_Doe@oncternal.com
4%
LastFir@oncternal.comDoeJoh@oncternal.com
3%

Frequently Asked Questions

Where is Oncternal Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Oncternal Therapeutics's main headquarters is located at 12230 El Camino Real Suite 300 San Diego, California 92130 US. The company has employees across 1 continents, including North America.

What is Oncternal Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Oncternal Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Oncternal Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Oncternal Therapeutics's official website is oncternal.com and has social profiles on LinkedIn.

How much revenue does Oncternal Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Oncternal Therapeutics's annual revenue reached $3.8M.

What is Oncternal Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Oncternal Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Oncternal Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Oncternal Therapeutics has approximately 28 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. B.Chief Medical Officer: S. Y.Chief Scientific Officer And Chief Technical Officer: R. K.. Explore Oncternal Therapeutics's employee directory with LeadIQ.

What industry does Oncternal Therapeutics belong to?

Minus sign iconPlus sign icon
Oncternal Therapeutics operates in the Biotechnology Research industry.

What technology does Oncternal Therapeutics use?

Minus sign iconPlus sign icon
Oncternal Therapeutics's tech stack includes Google AnalyticscdnjsjsDelivrAkamaiBusiness CatalystChoicesAmazon Web ServicesZURB Foundation.

What is Oncternal Therapeutics's email format?

Minus sign iconPlus sign icon
Oncternal Therapeutics's email format typically follows the pattern of . Find more Oncternal Therapeutics email formats with LeadIQ.

How much funding has Oncternal Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, Oncternal Therapeutics has raised $86M in funding. The last funding round occurred on Dec 09, 2020 for $86M.

When was Oncternal Therapeutics founded?

Minus sign iconPlus sign icon
Oncternal Therapeutics was founded in 2013.
Oncternal Therapeutics

Oncternal Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.

The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer; and a CAR-T therapy that targets ROR1 currently in preclinical development as a potential treatment for solid tumors and hematologic cancers.

Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments.

Section iconCompany Overview

Headquarters
12230 El Camino Real Suite 300 San Diego, California 92130 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $86M

    Oncternal Therapeutics has raised a total of $86M of funding over 7 rounds. Their latest funding round was raised on Dec 09, 2020 in the amount of $86M.

  • $10M

    Oncternal Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $86M

    Oncternal Therapeutics has raised a total of $86M of funding over 7 rounds. Their latest funding round was raised on Dec 09, 2020 in the amount of $86M.

  • $10M

    Oncternal Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.